{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:33:00Z","timestamp":1781775180910,"version":"3.54.5"},"reference-count":87,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Transplantation"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neutropenia is generally defined as an absolute neutrophil count in the circulation of less than 1500\/mm<jats:sup>3<\/jats:sup>and occurs in up to 25%\u201330% of pediatric solid organ transplant recipients (SOT) within the first year after transplantation. In the SOT population, neutropenia is most often a result of drug\u2010induced bone marrow suppression but can also be secondary to viral infection, nutritional deficiencies, lymphoproliferative infiltrate, and inherited causes. Outcomes for patients with neutropenia vary by degree of neutropenia and type of solid organ transplant. Management of neutropenia should begin by addressing the underlying cause, including reducing or removing medications when appropriate, treating infections, and addressing nutrient deficiencies; however, consultation with an experienced pediatric hematologist and use of granulocyte colony\u2010stimulating factor (G\u2010CSF) may be helpful in some cases. Overall, data on clinical outcomes for G\u2010CSF use remain limited, but observational studies may support its use in patients with infections or severe neutropenia.<\/jats:p>","DOI":"10.1111\/petr.14378","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T09:43:43Z","timestamp":1660988623000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neutropenia in pediatric solid organ transplant"],"prefix":"10.1111","volume":"26","author":[{"given":"Lyndsay A.","family":"Harshman","sequence":"first","affiliation":[{"name":"Stead Family Department of Pediatrics University of Iowa Carver College of Medicine Iowa City Iowa USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Williams","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology University of Minnesota Masonic Children's Hospital Minneapolis Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0584-7951","authenticated-orcid":false,"given":"Rachel M.","family":"Engen","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics University of Wisconsin Madison Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,8,20]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-074942"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13210"},{"key":"e_1_2_9_4_1","unstructured":"Neutropenia\u2013Hematology and Oncology\u2013Merck Manuals Professional Edition.https:\/\/www.merckmanuals.com\/professional\/hematology\u2010and\u2010oncology\/leukopenias\/neutropenia"},{"key":"e_1_2_9_5_1","unstructured":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE) Components and Organization CATEGORY.2006."},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.110288"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16992"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16978"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16982"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16977"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16991"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199512000-00007"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199902000-00006"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02699.x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.24332"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0594-0"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07320810"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12188"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13295"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0162-3109(00)00188-0"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.84"},{"key":"e_1_2_9_22_1","unstructured":"fda.CellCept\u00ae (mycophenolate mofetil capsules) (mycophenolate mofetil tablets) CellCept\u00ae Oral Suspension (mycophenolate mofetil for oral suspension) CellCept\u00ae Intravenous (mycophenolate mofetil hydrochloride for injection)."},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.02.038"},{"key":"e_1_2_9_24_1","first-page":"77","article-title":"Evaluation of neutropenia secondary to mycophenolate mofetil associated with valganciclovir in liver transplant patients","volume":"45","author":"Ferrer\u2010Mach\u00edn A","year":"2021","journal-title":"Farm Hosp"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000871"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12133"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14583"},{"key":"e_1_2_9_28_1","article-title":"Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients","volume":"12","author":"Wagner M","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404683"},{"key":"e_1_2_9_30_1","unstructured":"A Guide to Neutrophil Markers | Biocompare: The Buyer's Guide for Life Scientists.https:\/\/www.biocompare.com\/Editorial\u2010Articles\/577944\u2010A\u2010Guide\u2010to\u2010Neutrophil\u2010Markers\/"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31821c1e70"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1399-0012.2003.00102.x"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.4103\/2279-042X.200983"},{"key":"e_1_2_9_34_1","first-page":"1","article-title":"Drug\u2010induced hematological cytopenia in kidney transplantation and the challenges it poses for kidney transplant physicians","volume":"2018","author":"Khalil MAM","year":"2018","journal-title":"J Transp Secur"},{"key":"e_1_2_9_35_1","unstructured":"Highlights of Prescribing Information. These highlights do not include all the information needed to use THYMOGLOBULIN\u00ae safely and effectively. See full prescribing information for THYMOGLOBULIN. THYMOGLOBULIN\u00ae (anti\u2010thymocyte globulin [rabbit]) for injection for intravenous use."},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000184275.81396.45"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2014.06.001"},{"key":"e_1_2_9_38_1","first-page":"414","article-title":"Rituximab\u2010related late\u2010onset neutropenia in kidney transplant recipients treated for antibody\u2010mediated acute rejection","volume":"15","author":"Ahmadi F","year":"2017","journal-title":"Exp Clin Transplant"},{"key":"e_1_2_9_39_1","first-page":"210","article-title":"Clinical analysis of late\u2010onset neutropenia following rituximab","volume":"20","author":"Jia C","year":"2018","journal-title":"Advers Drug React J"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1984.tb17772.x"},{"key":"e_1_2_9_41_1","first-page":"1100","article-title":"Hematologic abnormalities after oral trimethoprim\u2010sulfamethoxazole therapy in children","volume":"135","author":"Asmar BI","year":"1981","journal-title":"Am J Dis Child"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-9-200705010-00009"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19708"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv342"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.07.012"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b21-00860"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2009.02.033"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02130-15"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2008.02.048"},{"key":"e_1_2_9_50_1","unstructured":"Valganciclovir: Drug information\u2013UpToDate.https:\/\/www.uptodate.com\/contents\/valganciclovir\u2010drug\u2010information?search=valganciclovir&source=panel_search_result&selectedTitle=1~55&usage_type=panel&kp_tab=drug_general&display_rank=1"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13512"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1542\/pir.29-1-12"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13652"},{"issue":"2","key":"e_1_2_9_54_1","first-page":"92","article-title":"Severe Neutropenia in Infectious Mononucleosis","volume":"131","author":"Hammond WP","year":"1979","journal-title":"West J Med"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2019.34.e203"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1701-z"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14131"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13634"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13058"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25215"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13130"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.1.181"},{"key":"e_1_2_9_63_1","first-page":"236","article-title":"Etiological causes and prognosis in children with neutropenia","volume":"8","author":"Ozdemir ZC","year":"2021","journal-title":"North Clin Istanbul"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-482612"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-7-200704030-00004"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1988.tb01192.x"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90391-7"},{"key":"e_1_2_9_68_1","first-page":"23","article-title":"The outcome of bacterial infection in subjects with benign familial leukopenia (BFL)","volume":"39","author":"Shoenfeld Y","year":"1985","journal-title":"Biomed Pharmacother"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2007.09.003"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15730"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07335.x"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705722"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21282"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15581"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16714"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-015-3113-7"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22242"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2018.06.009"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.8591"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.2000.020104.x"},{"key":"e_1_2_9_81_1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-0012.1996.tb00638.x","article-title":"Role of granulocyte colony stimulating factor (G\u2010CSF) in reversing neutropenia in renal allograft recipients","volume":"10","author":"Peddi VR","year":"1996","journal-title":"Clin Transpl"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13541"},{"key":"e_1_2_9_83_1","first-page":"1","article-title":"Impact of G\u2010CSF Therapy on Leukopenia and Acute Rejection Following Kidney Transplantation","volume":"12","author":"Schneider J","year":"2021","journal-title":"Int J Organ Transplant Med"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199911150-00014"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14202"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.01.104"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2014.07.070"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13976"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/petr.14378","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/petr.14378","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/petr.14378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T04:24:53Z","timestamp":1727843093000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/petr.14378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,20]]},"references-count":87,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1111\/petr.14378"],"URL":"https:\/\/doi.org\/10.1111\/petr.14378","archive":["Portico"],"relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"value":"1397-3142","type":"print"},{"value":"1399-3046","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,20]]},"assertion":[{"value":"2022-06-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e14378"}}